Tigermed IPO Initiation: Trade-Offs
Hangzhou Tigermed Consulting (300347 CH) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
419 Views
Shorts Increase on Alibaba, AIA, CNOOC; Decrease on Ping An, CCB, Meituan
We take a look at the latest SFC data released today evening on short position reporting in Hong Kong for the week ended 3 April 2020.Total short...
393 Views
HK Connect Weekly: Chinese Were Buying China Feihe, Meituan
In our weekly HK Connect Flow series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...
272 Views
Shorts Higher on Consumer Discretionary Stocks
We take a look at the latest SFC data released today evening on short position reporting in Hong Kong for the week ended 27 March 2020.Total short...
335 Views
Wuxi Biologics Placement: Another Pre-Lockup Placement but Past Deals Have Done Well
Wuxi Biologics Holdings is looking to raise up to US$513m by selling 3.2% of Wuxi Biologics (Cayman) Inc (2269 HK). This will be eight placement by...
544 Views